Matches in SemOpenAlex for { <https://semopenalex.org/work/W4376644803> ?p ?o ?g. }
- W4376644803 endingPage "2325" @default.
- W4376644803 startingPage "2325" @default.
- W4376644803 abstract "β-cryptoxanthin is a dietary carotenoid for which there have been few studies on the safety and pharmacokinetics following daily oral supplementation.90 healthy Asian women between 21 and 35 years were randomized into three groups: 3 and 6 mg/day oral β-cryptoxanthin, and placebo. At 2, 4, and 8 weeks of supplementation, plasma carotenoid levels were measured. The effects of β-cryptoxanthin on blood retinoid-dependent gene expression, mood, physical activity and sleep, metabolic parameters, and fecal microbial composition were investigated.β-cryptoxanthin supplementation for 8 weeks (3 and 6 mg/day) was found to be safe and well tolerated. Plasma β-cryptoxanthin concentration was significantly higher in the 6 mg/day group (9.0 ± 4.1 µmol/L) compared to 3 mg/day group (6.0 ± 2.6 µmol/L) (p < 0.03), and placebo (0.4 ± 0.1 µmol/L) (p < 0.001) after 8 weeks. Plasma all-trans retinol, α-cryptoxanthin, α-carotene, β-carotene, lycopene, lutein, and zeaxanthin levels were not significantly changed. No effects were found on blood retinol-dependent gene expression, mood, physical activity and sleep, metabolic parameters, and fecal microbial composition.Oral β-cryptoxanthin supplementation over 8 weeks lead to high plasma concentrations of β-cryptoxanthin, with no impact on other carotenoids, and was well tolerated in healthy women." @default.
- W4376644803 created "2023-05-17" @default.
- W4376644803 creator A5002446541 @default.
- W4376644803 creator A5011338575 @default.
- W4376644803 creator A5015141803 @default.
- W4376644803 creator A5017355562 @default.
- W4376644803 creator A5017835838 @default.
- W4376644803 creator A5020003474 @default.
- W4376644803 creator A5024814922 @default.
- W4376644803 creator A5031074495 @default.
- W4376644803 creator A5034239359 @default.
- W4376644803 creator A5034400760 @default.
- W4376644803 creator A5037820438 @default.
- W4376644803 creator A5050888857 @default.
- W4376644803 creator A5052849608 @default.
- W4376644803 creator A5054886117 @default.
- W4376644803 creator A5055187961 @default.
- W4376644803 creator A5058979039 @default.
- W4376644803 creator A5075706135 @default.
- W4376644803 creator A5076848338 @default.
- W4376644803 creator A5079016889 @default.
- W4376644803 creator A5080697479 @default.
- W4376644803 creator A5090674870 @default.
- W4376644803 date "2023-05-16" @default.
- W4376644803 modified "2023-09-29" @default.
- W4376644803 title "Safety, Tolerability, and Pharmacokinetics of β-Cryptoxanthin Supplementation in Healthy Women: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial" @default.
- W4376644803 cites W143336295 @default.
- W4376644803 cites W1519266993 @default.
- W4376644803 cites W1899584642 @default.
- W4376644803 cites W1939887442 @default.
- W4376644803 cites W1966225136 @default.
- W4376644803 cites W1975261845 @default.
- W4376644803 cites W1984284869 @default.
- W4376644803 cites W1995875735 @default.
- W4376644803 cites W1996299251 @default.
- W4376644803 cites W2021611003 @default.
- W4376644803 cites W2031060265 @default.
- W4376644803 cites W2031132826 @default.
- W4376644803 cites W2034824117 @default.
- W4376644803 cites W2038838030 @default.
- W4376644803 cites W2058361400 @default.
- W4376644803 cites W2060558491 @default.
- W4376644803 cites W2065809881 @default.
- W4376644803 cites W2088965479 @default.
- W4376644803 cites W2092076116 @default.
- W4376644803 cites W2103592914 @default.
- W4376644803 cites W2103825558 @default.
- W4376644803 cites W2110122595 @default.
- W4376644803 cites W2116092123 @default.
- W4376644803 cites W2117733750 @default.
- W4376644803 cites W2119319818 @default.
- W4376644803 cites W2129784234 @default.
- W4376644803 cites W2131189301 @default.
- W4376644803 cites W2132926880 @default.
- W4376644803 cites W2151487996 @default.
- W4376644803 cites W2153921240 @default.
- W4376644803 cites W2166446169 @default.
- W4376644803 cites W2210472715 @default.
- W4376644803 cites W2265846640 @default.
- W4376644803 cites W2277738248 @default.
- W4376644803 cites W2329483624 @default.
- W4376644803 cites W2334286404 @default.
- W4376644803 cites W2401404581 @default.
- W4376644803 cites W2513787404 @default.
- W4376644803 cites W2513994496 @default.
- W4376644803 cites W2552428245 @default.
- W4376644803 cites W2592367925 @default.
- W4376644803 cites W2803191377 @default.
- W4376644803 cites W2807194798 @default.
- W4376644803 cites W2896638680 @default.
- W4376644803 cites W2945471055 @default.
- W4376644803 cites W2963276645 @default.
- W4376644803 cites W2965153655 @default.
- W4376644803 cites W2965961964 @default.
- W4376644803 cites W2977347340 @default.
- W4376644803 cites W3028009029 @default.
- W4376644803 cites W3034245282 @default.
- W4376644803 cites W3094567110 @default.
- W4376644803 cites W3113460284 @default.
- W4376644803 cites W3118725273 @default.
- W4376644803 cites W3119573875 @default.
- W4376644803 cites W3124165136 @default.
- W4376644803 cites W3124410800 @default.
- W4376644803 cites W4253184049 @default.
- W4376644803 cites W4289941945 @default.
- W4376644803 cites W4304013978 @default.
- W4376644803 doi "https://doi.org/10.3390/nu15102325" @default.
- W4376644803 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37242207" @default.
- W4376644803 hasPublicationYear "2023" @default.
- W4376644803 type Work @default.
- W4376644803 citedByCount "0" @default.
- W4376644803 crossrefType "journal-article" @default.
- W4376644803 hasAuthorship W4376644803A5002446541 @default.
- W4376644803 hasAuthorship W4376644803A5011338575 @default.
- W4376644803 hasAuthorship W4376644803A5015141803 @default.
- W4376644803 hasAuthorship W4376644803A5017355562 @default.
- W4376644803 hasAuthorship W4376644803A5017835838 @default.
- W4376644803 hasAuthorship W4376644803A5020003474 @default.